GoodmanNF,CobinRH,FutterweitW,GlueckJS,LegroRS,EndoPract, 2015.C a r m i n a E . A m e r i c a n A s s o c i a t i o n o f C l i n i c a l Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1, 21 1291 -300
PasqualiR,ZanottiL,FanelliF,MezzulloM,FazziniA,Morselli Labate, .Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective,J Clin Endo & Metabol 20161 2013 -22
GoodmanNF,CobinRH,FutterweitW,GlueckJS,LegroRS,EndoPract, 2015.C a r m i n a E . A m e r i c a n A s s o c i a t i o n o f C l i n i c a l Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 2, 21 1415 -26
LegroRS,ArslanianSA,EhrmannDA,HoegerKM,MuradMH,PasqualiR, .Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline,J Clin Endo & Metabol 20131 4565 -92
MenonM,RamachandranV, .Antithyroid peroxidase antibodies in women with polycystic ovary syndrome,J Obstet and Gynecol India 20171 61 -5
PalombaS,De WildeMA,FalboA,KosterMP,La SalaGB,FauserBC, .Pregnancy complications in women with polycystic ovary syndrome,Hum repro update. 201527;21 575 -92
ForoozanfardF,TalebiM,SamimiM,MehrabiS,BadehnooshB,JamilianM, 2017.Effect of two different doses of vitamin D supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial,Horm and Metabol Rese 49 612 -7
CaldwellAS,MiddletonLJ,JimenezM,DesaiR,McMahonAC,AllanCM, .Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models,Endocrinol 20141 3146 -59
SadrzadehS,PainterRC,LambalkCB, .Developmental origins of polycystic ovary syndrome (PCOS), a case control study comparing birth weight in women with PCOS and control group,Gynecol Endocrinol 20162 856 -9
LivadasS,PappasC,KarachaliosA,MarinakisE,ToliaN,DrakouM, 2014.Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome,Endo 47 631 -8
ConwayG,DewaillyD,Diamanti-KandarakisE., 2015.The polycystic ovary syndrome. A position statement from the European Society of Endocrinology,Repro Endocrinol 25 32 -52
PinolaP,PuukkaK,PiltonenTT,PuurunenJ,VankyE,Sundström-PoromaaI, 2017.Normo-and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life,Fertil and steril 107 788 -95
MoranC,ArriagaM,Arechavaleta-VelascoF,MoranS., 2015.Adrenal androgen excess and body mass index in polycystic ovary syndrome,J Clin Endocrinol & Metabol 100 942 -50
EzehU,YildizBO,AzzizR, 2013.Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome,J Clin Endocrinol & Metabol 98 1088 -96
JohamAE,TeedeHJ,RanasinhaS,ZoungasS,BoyleJ, 2015.Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study,J women's health 24 299 -307
PorcaroG,BizzarriM,MonastraG,FilatiP,UnferV, 2016.Strategies for the treatment of polycystic ovary syndrome (PCOS) women: the role of myoinositol (MI) and d-chiroinositol (DCI) between diet and therapy. Polycystic ovary syndrome (PCOS): clinical aspects, potential complications and dietary management, -
ClarkNM,PodolskiAJ,BrooksED,ChizenDR,PiersonRA,LehotayDC, 2014.Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome,Repro Sci 21 1034 -43
KelleyCE,BrownAJ,DiehlAM,SetjiTL, 2014.Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome,World J Gastroenterol 20 14172 -